- Companies
- Asker Healthcare Group
Asker Healthcare Group Valuation Multiples
Asker Healthcare Group is valued at $2.7B as of October 2026, a 1.7x revenue multiple. In the last 12 months, Asker Healthcare Group revenue was $1.9B and Asker Healthcare Group EBITDA was $241M.
Asker Healthcare Group Overview
About Asker Healthcare Group
Asker Healthcare Group AB is a provider of medical products and solutions that drive progress in the European healthcare sector. The company is engaged in building and acquiring companies to support the healthcare system to improve patient outcomes, reduce the total cost of care, and ensure a fair and sustainable value chain. The company also offers a range of value-added solutions to support its suppliers and customers in, for example, market access, efficiency, and sustainability.
Founded
2006
HQ
Employees
4.0K
Website
Sectors
Financials (LTM)
EV
$3.2B
Valuation Multiples
Start free trialAsker Healthcare Group Financials
Asker Healthcare Group reported last 12-month revenue of $1.9B and EBITDA of $241M.
In the same LTM period, Asker Healthcare Group generated $676M in gross profit, $241M in EBITDA, and $80M in net income.
Revenue (LTM)
Asker Healthcare Group P&L
In the most recent fiscal year, Asker Healthcare Group reported revenue of $1.7B and EBITDA of $168M.
Asker Healthcare Group is profitable as of last fiscal year, with gross margin of 41%, EBITDA margin of 10%, and net margin of 3%.
Financial data powered by Morningstar, Inc.
Asker Healthcare Group Stock Performance
Asker Healthcare Group has current market cap of $2.7B, and enterprise value of $3.2B.
Market Cap Evolution
Asker Healthcare Group's stock price is $6.93.
Asker Healthcare Group share price increased by 3.9% in the last 30 days, and decreased by 24.0% in the last year.
Asker Healthcare Group has an EPS (earnings per share) of $0.13.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3.2B | $2.7B | 0.7% | 3.9% | -18.8% | -24.0% | $0.13 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAsker Healthcare Group Valuation Multiples
Asker Healthcare Group trades at 1.7x EV/Revenue multiple, and 13.4x EV/EBITDA.
EV / Revenue (LTM)
Asker Healthcare Group Financial Valuation Multiples
As of October 16, 2026, Asker Healthcare Group has market cap of $2.7B and EV of $3.2B.
Asker Healthcare Group has a P/E ratio of 33.4x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Asker Healthcare Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Asker Healthcare Group Margins & Growth Rates
Asker Healthcare Group grew revenue by 15% and EBITDA by 46% in the last fiscal year.
In the most recent fiscal year, Asker Healthcare Group reported gross margin of 41%, EBITDA margin of 10%, and net margin of 3%.
Asker Healthcare Group Margins
Asker Healthcare Group Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Asker Healthcare Group Operational KPIs
Asker Healthcare Group's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.
Asker Healthcare Group's Rule of 40 is 28% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Asker Healthcare Group's Rule of X is 51% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Asker Healthcare Group Competitors
Asker Healthcare Group competitors include Kpj Healthcare, Meinian Onehealth, Guardian Pharmacy Service, Acadia Healthcare, Dallah Healthcare, IKS Health, Krishna Institute, Pediatrix, Topchoice Medical and Draegerwerk.
Most Asker Healthcare Group public comparables operate across Hospitals & Clinics.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $1B | $256M | 3.3x | 3.1x | 13.5x | 13.0x | |||
| $1.5B | $306M | 2.2x | 2.3x | 11.2x | 14.5x | |||
| $1.4B | $96M | 1.7x | 1.7x | 25.6x | 19.5x | |||
| $3.3B | ($738M) | 1.7x | 1.6x | (7.4x) | 9.1x | |||
| $1.1B | $246M | 3.2x | 3.0x | 14.1x | 13.6x | |||
| $336M | $114M | 9.1x | 7.1x | 26.8x | 22.6x | |||
| $407M | $84M | 8.6x | 7.3x | 41.6x | 34.8x | |||
| $1.9B | $274M | 1.3x | 1.3x | 9.0x | 8.6x | |||
This data is available for Pro users. Sign up to see all Asker Healthcare Group competitors and their valuation data. Start Free Trial | ||||||||
Acquisitions by Asker Healthcare Group
Asker Healthcare Group has acquired 31 companies to date.
Last acquisition by Asker Healthcare Group was on September 3rd 2026. Asker Healthcare Group acquired Labo Clinic for undisclosed valuation.
Latest Acquisitions by Asker Healthcare Group
| Description | Labo Clinic is a medical equipment distributor serving hospitals and clinics in Poland with sales, training, and technical support. | Med Kjemi AS is a supplier of laboratory equipment and consumables for healthcare and clinical diagnostics. | AmberCell Solutions is a medical supply firm that delivers protective gear, diagnostic equipment, inventory tools, and automation solutions to healthcare providers. | Murray Surgical is a distributor of surgical tools and related supplies based in Ireland. The firm maintains an inventory exceeding one hundred thousand items spanning orthopedics, minimally invasive techniques, pediatric dental work, pain management, and oral procedures. | |
| HQ Country | |||||
| HQ City | Olsztyn | Oslo | Klaipeda | Dublin | |
| Deal Date | 3 Sep 2026 | 1 Sep 2026 | 18 Aug 2026 | 2 Jul 2026 | |
| Valuation | undisclosed | undisclosed | undisclosed | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Asker Healthcare Group acquisitions and their M&A valuation multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Asker Healthcare Group
| When was Asker Healthcare Group founded? | Asker Healthcare Group was founded in 2006. |
| Where is Asker Healthcare Group headquartered? | Asker Healthcare Group is headquartered in Sweden. |
| How many employees does Asker Healthcare Group have? | As of today, Asker Healthcare Group has over 4K employees. |
| Who is the CEO of Asker Healthcare Group? | Asker Healthcare Group's CEO is Johan Falk. |
| Is Asker Healthcare Group publicly listed? | Yes, Asker Healthcare Group is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Asker Healthcare Group? | Asker Healthcare Group trades under ASKER ticker. |
| When did Asker Healthcare Group go public? | Asker Healthcare Group went public in 2025. |
| Who are competitors of Asker Healthcare Group? | Asker Healthcare Group main competitors include Kpj Healthcare, Meinian Onehealth, Guardian Pharmacy Service, Acadia Healthcare, Dallah Healthcare, IKS Health, Krishna Institute, Pediatrix, Topchoice Medical, Draegerwerk. |
| What is the current market cap of Asker Healthcare Group? | Asker Healthcare Group's current market cap is $2.7B. |
| What is the current revenue of Asker Healthcare Group? | Asker Healthcare Group's last 12 months revenue is $1.9B. |
| What is the current revenue growth of Asker Healthcare Group? | Asker Healthcare Group revenue growth (NTM/LTM) is 8%. |
| What is the current EV/Revenue multiple of Asker Healthcare Group? | Current revenue multiple of Asker Healthcare Group is 1.7x. |
| What is the current EBITDA of Asker Healthcare Group? | Asker Healthcare Group's last 12 months EBITDA is $241M. |
| What is Asker Healthcare Group's EBITDA margin? | Asker Healthcare Group's last 12 months EBITDA margin is 12%. |
| What is the current EV/EBITDA multiple of Asker Healthcare Group? | Current EBITDA multiple of Asker Healthcare Group is 13.4x. |
| What is the current FCF of Asker Healthcare Group? | Asker Healthcare Group's last 12 months FCF is $77M. |
| What is Asker Healthcare Group's FCF margin? | Asker Healthcare Group's last 12 months FCF margin is 4%. |
| What is the current EV/FCF multiple of Asker Healthcare Group? | Current FCF multiple of Asker Healthcare Group is 42.1x. |
| How many companies Asker Healthcare Group has acquired to date? | As of October 2026, Asker Healthcare Group has acquired 31 companies. |
| What was the largest acquisition by Asker Healthcare Group? | $14M acquisition of Wolturnus on 1st July 2024 was the largest M&A Asker Healthcare Group has done to date. |
| What companies Asker Healthcare Group acquired? | Asker Healthcare Group acquired Wolturnus, Mayumana Healthcare, Aspironix, MELET SCHLOESING Laboratoires, SUMMED Finland, Kvinto, Hospital Services Limited, meetB Group, Vegro, Health Net Connections, and 21 other companies. |
| In how many companies Asker Healthcare Group has invested to date? | Asker Healthcare Group hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Asker Healthcare Group
Lists including Asker Healthcare Group
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




